CompanyDrug

Sichuan Kelun Pharmaceutical’s RET Inhibitor A400 Earns FDA Orphan Drug Designation

CompanyMedical Device

Yantai Dongcheng Pharmaceutical Gets Green Light for Prostate Cancer Diagnostic Drug Trial

CompanyDeals

OrbusNeich Medical Group to Acquire Majority Stake in Indonesian Distributor PT Revass Utama Medika

CompanyDrug

Kintor Pharmaceutical’s KX-826 Shows Promising Results in Phase III AGA Clinical Trial

CompanyDrug

EirGenix’s Trastuzumab Biosimilar Receives European Commission Marketing Approval

CompanyDeals

Broncus Medical and Hangzhou Norchant Terminate Licensing Agreement with Cancellation Fee

Company

FDA Raises Concerns Over Research Conditions at Roche’s Genentech Trial Site

CompanyDrug

Jiangxi Jemincare Group Secures NMPA Approval for Generic Ibrance Capsules

Policy / RegulatoryR&D

China’s CDE Releases Draft Guidelines for Decentralized Trials in Rare Disease Drug Development

CompanyLegal / IP

AbbVie Sues to Protect Rinvoq from Generic Competition in the US Market

CompanyDrug

Novo Nordisk Sets February 2024 Launch for Wegovy in Japan, Expanding into Asia

CompanyDrug

Jiangsu Hengrui Pharmaceuticals Receives NMPA Approval for Phase Ib/II Study of Dalpiciclib and HRS-8080